150 related articles for article (PubMed ID: 36858557)
21. Application of Intestinal Epithelial Cells Differentiated from Human Induced Pluripotent Stem Cells for Studies of Prodrug Hydrolysis and Drug Absorption in the Small Intestine.
Akazawa T; Yoshida S; Ohnishi S; Kanazu T; Kawai M; Takahashi K
Drug Metab Dispos; 2018 Nov; 46(11):1497-1506. PubMed ID: 30135242
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the Human Intestinal Drug Transport with Ussing Chamber System Incorporating Freshly Isolated Human Jejunum.
Michiba K; Maeda K; Kurimori K; Enomoto T; Shimomura O; Takeuchi T; Nishiyama H; Oda T; Kusuhara H
Drug Metab Dispos; 2021 Jan; 49(1):84-93. PubMed ID: 33087448
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of mitogen-activated protein kinase kinase, DNA methyltransferase, and transforming growth factor-β promotes differentiation of human induced pluripotent stem cells into enterocytes.
Kodama N; Iwao T; Kabeya T; Horikawa T; Niwa T; Kondo Y; Nakamura K; Matsunaga T
Drug Metab Pharmacokinet; 2016 Jun; 31(3):193-200. PubMed ID: 27161454
[TBL] [Abstract][Full Text] [Related]
24. Functional Comparison of Human Colonic Carcinoma Cell Lines and Primary Small Intestinal Epithelial Cells for Investigations of Intestinal Drug Permeability and First-Pass Metabolism.
Yamaura Y; Chapron BD; Wang Z; Himmelfarb J; Thummel KE
Drug Metab Dispos; 2016 Mar; 44(3):329-35. PubMed ID: 26700954
[TBL] [Abstract][Full Text] [Related]
25. [Generation of human iPS cell-derived hepatocytes and enterocytes for application to drug disposition studies].
Iwao T; Matsunaga T
Nihon Yakurigaku Zasshi; 2019; 154(2):72-77. PubMed ID: 31406046
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Barrier Functions in Human iPSC-Derived Intestinal Epithelium.
Yamada S; Kanda Y
Methods Mol Biol; 2021; 2367():27-35. PubMed ID: 33661485
[TBL] [Abstract][Full Text] [Related]
27. The development of a functional human small intestinal epithelium model for drug absorption.
Kwon O; Jung KB; Lee KR; Son YS; Lee H; Kim JJ; Kim K; Lee S; Song YK; Jung J; Park K; Kim DS; Son MJ; Lee MO; Han TS; Cho HS; Oh SJ; Chung H; Kim SH; Chung KS; Kim J; Jung CR; Son MY
Sci Adv; 2021 Jun; 7(23):. PubMed ID: 34078609
[TBL] [Abstract][Full Text] [Related]
28. Effects of human induced pluripotent stem cell-derived intestinal organoids on colitis-model mice.
Nakanishi A; Toyama S; Onozato D; Watanabe C; Hashita T; Iwao T; Matsunaga T
Regen Ther; 2022 Dec; 21():351-361. PubMed ID: 36161099
[TBL] [Abstract][Full Text] [Related]
29. Establishment of a novel culture method for maintaining intestinal stem cells derived from human induced pluripotent stem cells.
Kondo S; Mizuno S; Hashita T; Iwao T; Matsunaga T
Biol Open; 2020 Jan; 9(1):. PubMed ID: 31919043
[TBL] [Abstract][Full Text] [Related]
30. Human small intestinal epithelial cells differentiated from adult intestinal stem cells as a novel system for predicting oral drug absorption in humans.
Takenaka T; Harada N; Kuze J; Chiba M; Iwao T; Matsunaga T
Drug Metab Dispos; 2014 Nov; 42(11):1947-54. PubMed ID: 25200868
[TBL] [Abstract][Full Text] [Related]
31. Air-liquid interface culture and modified culture medium promote the differentiation of human induced pluripotent stem cells into intestinal epithelial cells.
Shirai K; Qiu S; Minowa H; Hashita T; Iwao T; Matsunaga T
Drug Metab Pharmacokinet; 2024 Apr; 55():100994. PubMed ID: 38452616
[TBL] [Abstract][Full Text] [Related]
32. Generation of enterocyte-like cells with pharmacokinetic functions from human induced pluripotent stem cells using small-molecule compounds.
Iwao T; Kodama N; Kondo Y; Kabeya T; Nakamura K; Horikawa T; Niwa T; Kurose K; Matsunaga T
Drug Metab Dispos; 2015 Apr; 43(4):603-10. PubMed ID: 25650381
[TBL] [Abstract][Full Text] [Related]
33. Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine.
Suzuki H; Sugiyama Y
Eur J Pharm Sci; 2000 Nov; 12(1):3-12. PubMed ID: 11121729
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of Human Jejunal Spheroid-Derived Differentiated Intestinal Epithelial Cells for the Prediction of Intestinal Drug Absorption in Humans.
Michiba K; Maeda K; Shimomura O; Miyazaki Y; Hashimoto S; Oda T; Kusuhara H
Drug Metab Dispos; 2022 Mar; 50(3):204-213. PubMed ID: 34992074
[TBL] [Abstract][Full Text] [Related]
35. Using human iPS cell-derived enterocytes as novel in vitro model for the evaluation of human intestinal mucosal damage.
Kondo S; Mizuno S; Hashita T; Iwao T; Matsunaga T
Inflamm Res; 2018 Dec; 67(11-12):975-984. PubMed ID: 30317465
[TBL] [Abstract][Full Text] [Related]
36. Intestinal organoids as an in vitro platform to characterize disposition, metabolism, and safety profile of small molecules.
Kourula S; Derksen M; Jardi F; Jonkers S; van Heerden M; Verboven P; Theuns V; Van Asten S; Huybrechts T; Kunze A; Frazer-Mendelewska E; Lai KW; Overmeer R; Roos JL; Vries RGJ; Boj SF; Monshouwer M; Pourfarzad F; Snoeys J
Eur J Pharm Sci; 2023 Sep; 188():106481. PubMed ID: 37244450
[TBL] [Abstract][Full Text] [Related]
37. Suspension culture of human induced pluripotent stem cell-derived intestinal organoids using natural polysaccharides.
Ogawa I; Onozato D; Anno S; Hayashi H; Kanaki T; Iwao T; Matsunaga T
Biomaterials; 2022 Sep; 288():121696. PubMed ID: 36038421
[TBL] [Abstract][Full Text] [Related]
38. Human Primary Cell-Based Organotypic Microtissues for Modeling Small Intestinal Drug Absorption.
Ayehunie S; Landry T; Stevens Z; Armento A; Hayden P; Klausner M
Pharm Res; 2018 Feb; 35(4):72. PubMed ID: 29476278
[TBL] [Abstract][Full Text] [Related]
39. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.
Darwich AS; Neuhoff S; Jamei M; Rostami-Hodjegan A
Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140
[TBL] [Abstract][Full Text] [Related]
40. Gellan Gum Promotes the Differentiation of Enterocytes from Human Induced Pluripotent Stem Cells.
Qiu S; Kabeya T; Ogawa I; Anno S; Hayashi H; Kanaki T; Hashita T; Iwao T; Matsunaga T
Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33050367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
